Header Logo

Connection

Caroline Alper to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Caroline Alper has written about Cost-Benefit Analysis.
Caroline Alper
Connection Strength
0.043
Cost-Benefit Analysis
  1. Gabot A, Lavitas P, Bacon R, Pomfret TC, Taylor M, Coelho A, Greenwood BC, Alper CJ, Clements KM, Lenz K. Cost-benefit analysis of sacubitril/valsartan in a Medicaid population. Am J Manag Care. 2022 07; 28(7):349-352.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.